Experienced in IgG4-Related Disease

Dr. Raymond L. Comenzo

Hematology Oncology | Hematology
Pratt Medical Group Inc
800 Washigton St, 
Boston, MA 
Accepting New Patients

Experienced in IgG4-Related Disease
Pratt Medical Group Inc
800 Washigton St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Raymond Comenzo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Comenzo is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Cardiac Amyloidosis, Bone Marrow Transplant, and Tissue Biopsy. Dr. Comenzo is currently accepting new patients.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Licenses
Internal Medicine in NY
Hospital Affiliations
Tufts Medical Center
Lowell General Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

PRATT MEDICAL GROUP INC
800 Washigton St, Boston, MA 02111
Call: 617-636-5000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Ixazomib Citrate, Lenalidomide
Study Phase: Phase 3
Screening to Improve Survival in AL Amyloidosis
Screening to Improve Survival in AL Amyloidosis
Enrollment Status: Completed
Publish Date: October 28, 2024
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study of NEOD001 Plus Standard of Care Versus Placebo Plus Standard of Care in Subjects With Light Chain (AL) Amyloidosis
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase I Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
A Phase I Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Enrollment Status: Terminated
Publish Date: August 21, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Enrollment Status: Terminated
Publish Date: August 20, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Who Were Previously Enrolled in Study NEOD001-201 (PRONTO)
A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Who Were Previously Enrolled in Study NEOD001-201 (PRONTO)
Enrollment Status: Terminated
Publish Date: March 26, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

126 Total Publications

Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.
Screening for Systemic Light-Chain Amyloidosis in Patients Over 60 with λ Monoclonal Gammopathies.
Journal: Journal of clinical medicine
Published: May 14, 2025
View All 126 Publications
Similar Doctors
Advanced in IgG4-Related Disease
Dr. Adam R. Miller
Hematology Oncology | Hematology | Oncology
Advanced in IgG4-Related Disease
Dr. Adam R. Miller
Hematology Oncology | Hematology | Oncology

Massachusetts General Physicians Organization Inc

81 Highland Ave, 
Salem, MA 
 (13.7 miles away)
978-741-1200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Adam Miller is a Hematologist Oncology specialist and a Hematologist in Salem, Massachusetts. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Miller is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Larissa Bornikova
Hematology Oncology | Transfusion Medicine | Hematology
Experienced in IgG4-Related Disease
Dr. Larissa Bornikova
Hematology Oncology | Transfusion Medicine | Hematology

The General Hospital Corporation

55 Fruit St, 
Boston, MA 
 (0.9 miles away)
617-726-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Larissa Bornikova is a Hematologist Oncology specialist and a Transfusion Medicine provider in Boston, Massachusetts. Dr. Bornikova is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Von Willebrand Disease (VWD), Heyde Syndrome, Hemochromatosis, and Congenital Afibrinogenemia. Dr. Bornikova is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Ambreen Ijaz
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Ambreen Ijaz
Hematology Oncology | Hematology | Oncology

Affinity Physicians Llc.

455 Toll Gate Rd, 
Warwick, RI 
 (49.4 miles away)
401-737-7010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ambreen Ijaz is a Hematologist Oncology specialist and a Hematologist in Warwick, Rhode Island. Dr. Ijaz is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Comenzo's expertise for a condition
ConditionClose
  • Elite
  • Cardiac Amyloidosis
    Dr. Comenzo is
    Elite
    . Learn about Cardiac Amyloidosis.
    See more Cardiac Amyloidosis experts
  • Multiple Myeloma
    Dr. Comenzo is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Primary Amyloidosis
    Dr. Comenzo is
    Elite
    . Learn about Primary Amyloidosis.
    See more Primary Amyloidosis experts
  • Distinguished
  • Cerebral Amyloid Angiopathy
    Dr. Comenzo is
    Distinguished
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Familial Transthyretin Amyloidosis
    Dr. Comenzo is
    Distinguished
    . Learn about Familial Transthyretin Amyloidosis.
    See more Familial Transthyretin Amyloidosis experts
  • Hereditary Cerebral Amyloid Angiopathy
    Dr. Comenzo is
    Distinguished
    . Learn about Hereditary Cerebral Amyloid Angiopathy.
    See more Hereditary Cerebral Amyloid Angiopathy experts
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Dr. Comenzo is
    Distinguished
    . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
    See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
  • Primary Localized Cutaneous Amyloidosis
    Dr. Comenzo is
    Distinguished
    . Learn about Primary Localized Cutaneous Amyloidosis.
    See more Primary Localized Cutaneous Amyloidosis experts
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. Comenzo is
    Distinguished
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
View All 9 Distinguished Conditions
  • Advanced
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Comenzo is
    Advanced
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Comenzo is
    Advanced
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Bone Marrow Transplant
    Dr. Comenzo is
    Advanced
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Schnitzler Syndrome
    Dr. Comenzo is
    Advanced
    . Learn about Schnitzler Syndrome.
    See more Schnitzler Syndrome experts
  • Secondary Systemic Amyloidosis
    Dr. Comenzo is
    Advanced
    . Learn about Secondary Systemic Amyloidosis.
    See more Secondary Systemic Amyloidosis experts
  • Transthyretin Amyloid Cardiomyopathy
    Dr. Comenzo is
    Advanced
    . Learn about Transthyretin Amyloid Cardiomyopathy.
    See more Transthyretin Amyloid Cardiomyopathy experts
  • Experienced
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Comenzo is
    Experienced
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Adult T-Cell Leukemia
    Dr. Comenzo is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Agranulocytosis
    Dr. Comenzo is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Bone Marrow Aspiration
    Dr. Comenzo is
    Experienced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Childhood Acute Myeloid Leukemia
    Dr. Comenzo is
    Experienced
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
  • Diffuse Large B-Cell Lymphoma (DLBCL)
    Dr. Comenzo is
    Experienced
    . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
    See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved